In this study, we provide data to show that HSA-Trx exerted anti-oxidative and anti-inflammatory effects, and showed an improving effect on the progression of heart failure such as Dox-induced cardiomyopathy and fibrosis (Figure 5). This evidence concerns the gene TXN and cardiomyopathy.